GCCPL has forward integrated from B2B in finished formulations to create their own end user existence felt. Marketing branded generics ethically is the aim of the department and is focused only into pharmaceutical products for use in Interventional Cardiology. This recent 3 year old business wing was developed around an unconventional concept of identifying different products keeping the end use of the basket of products along the same lines of Intraventional Cardiology. This department is growing exponentially and is aimed at being the top player in Intraventional Cardiology in India in the next few years.

Brand Name API Indication Strength
Eptiday bolus Eptifibatide Eptiday is an ideal GP IIb/IIIa inhibitor used to reduce the risk of acute cardiac ischemic events  in patients with unstable angina or NSTEMI- Acute coronary syndrome; both in patients who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronary intervention (PCI) 20mg / 10ml
Eptiday infusion Eptifibatide 75mg / 100ml
Bivaday Bivalirudin Bivaday is indicated for use as an anti coagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA) 250mg
Tiroday Tirofiban Tiroday is indicated to reduce the rate of thrombotic cardiovascualar events in patients with NSTEMI-Acute coronary syndrome 5mg/100ml